Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.
about
Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Immunomonitoring of MSC-Treate ...... ut Indicates Treatment Safety.
@en
Immunomonitoring of MSC-Treate ...... ut Indicates Treatment Safety.
@nl
type
label
Immunomonitoring of MSC-Treate ...... ut Indicates Treatment Safety.
@en
Immunomonitoring of MSC-Treate ...... ut Indicates Treatment Safety.
@nl
prefLabel
Immunomonitoring of MSC-Treate ...... ut Indicates Treatment Safety.
@en
Immunomonitoring of MSC-Treate ...... ut Indicates Treatment Safety.
@nl
P2093
P2860
P50
P1476
Immunomonitoring of MSC-Treate ...... ut Indicates Treatment Safety.
@en
P2093
Johanna Castrén
Kaarina Lähteenmäki
Maija Itälä-Remes
Matti Korhonen
Urpu Salmenniemi
P2860
P304
P356
10.1016/J.OMTM.2018.02.001
P577
2018-02-08T00:00:00Z